imugene limited (asx:imu) three complete responses in azer-cel phase 1b trial
Published 13 days ago • 539 plays • Length 3:51Download video MP4
Download video MP3
Similar videos
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
1:43
imugene’s asx imu azer cel car t therapy trial shows encouraging results in blood cancer
-
25:35
investor webinar: azer-cel trial update, september 2024
-
7:40
imugene limited (asx: imu) emergence 2024: presentation by leslie chong, managing director and ceo
-
5:30
imugene releases final data from phase 2 her vaxx study
-
26:23
imugene (asx:imu) presentation, nwr virtual healthcare conference
-
33:41
imugene investor webinar | acquisition of license for azer-cel cell therapy
-
6:37
leslie chong discusses imugene's strategic partnership with kincell bio | ausbiz interview
-
4:14
imugene doses first patient in phase 1 oncarlytics iv infusion combination trial
-
32:27
how imugene is turning viruses into cancer-fighting heroes!
-
15:06
imugene (asx:imu) | jmm & éthica capital innovation & investment insights | may 2024
-
5:04
imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024
-
4:14
imugene (asx:imu) doses first patient in iv arm of phase 1 oncarlytics trial targeting solid cancers
-
20:44
imugene limited: asx small and mid cap conference march 2024
-
18:05
investor webinar – imugene limited (asx:imu) & kincell bio strategic partnership investor webinar
-
4:28
imugene with proactive at asx small and mid cap conference
-
10:00
imugene begins vaxinia trial for bile tract cancer
-
26:23
imugene (asx: imu) presentation, nwr virtual healthcare conference
-
4:52
'the why' | imugene, developing cancer immunotherapies asx: imu